Compare Cardinal Health Inc (CAH) vs Meta Platforms Inc (META) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Meta Platforms Inc — how do they compare? Cardinal Health Inc trades at $228.22 (market cap $53.89B), while Meta Platforms Inc trades at $657.66 (market cap $1.68T). The key difference: Meta Platforms Inc is far larger — about 31.2× Cardinal Health Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | META | |
|---|---|---|
Market Cap | $53.89B | $1.68T |
Sector | Health | Media |
52-Week High | $239.71 | $790.00 |
52-Week Low | $146.04 | $525.72 |
Enterprise Value | $58.87B | $1.68T |
Dividend Yield | 0.89% | 0.32% |
Volume | — | 24,093,972 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
META stock trades at $665.31, up 1.31% over the past 24 hours, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, including Q1 2026 EPS of $10.44 versus $6.70 expected, driven by revenue growth to $201.0 billion in 2025. Positive sentiment is fueled by the launch of its Muse Spark AI model and a $21 billion deal with CoreWeave, though legal challenges over youth addiction persist.
Outlook remains favorable given analyst consensus price target of $815.44 and 79% buy ratings, supported by high profitability margins and AI monetization potential. Key risks include regulatory lawsuits and elevated capital expenditures impacting cash flow. The stock offers growth exposure but requires monitoring of legal outcomes and competitive dynamics in social media and AI infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Meta Platforms Inc
Meta Platforms Inc., doing business as Meta and previously known as Facebook Inc. It's a company that acts as a parent platform for Facebook, Messenger, Instagram, Whatsapp, Oculus and other subsidiaries. Among these platforms, Facebook is the number one social media platform in terms of the number of active users.
Read more on META →
